Skip to main content
. 2021 Nov 18;14:17562848211042171. doi: 10.1177/17562848211042171

Table 1.

Main characteristics of the studies included. Patients treated with EUS-guided RFA technique. NA: not applicable, F: female, M: male, RFA: radifrequency ablation, p.: patient, EUS: endoscopic ultrasound.

Study population Country No. of patients with insulinoma Gender (M\F) Age (y) Indication for EUS-RFA No of insulinomas No of sessions No of passes Watts RFA duration (s) Glucose (mmol/L) Insulin (pmol/L) C-peptid (pmol/L) Type of adverse event
before RFA after RFA before RFA after RFA before RFA after RFA
Bas-Cutrina et al. 22 Spain 1 F 63 comorbidity 1 1 3 10 360 NA NA NA NA NA NA no
Choi et al. 25 Korea 1 M 34 refuse and high surgical risk 1 1 3 50 10 NA NA NA NA NA NA no
De Nucci et al. 28 Italy 1 F 76 comorbidity 1 1 2 10 60 1.9 NA NA NA NA NA no
Godat et al. 30 Switzerland 1 NA NA NA 1 1 3 50 10 NA NA NA NA NA NA abd. pain
Jonica and Wagh 31 USA 1 F 57 comorbidity 1 1 5 30 20 2.22 7.66 257 NA NA NA no
Kandula et al. 32 India 1 F 41 refuse surgery 2 NA NA NA NA 2.22 NA NA NA NA NA abd. pain, acute pancreatitis
Kluz et al. 34 Poland 1 M 40 refuse surgery 1 3 NA 50 10 NA NA NA NA NA NA acute necro. pancreatitis
Oleinikov et al. 40 Israel 7 M 44 refuse surgery 1 1 NA 10-50 5-12 3.38 ± 0.34 6.61 ± 0.13 NA NA NA NA no
M 65 1 1 50 5-12
M 61 1 1 10-50 5-12
M 73 1 1 10-50 5-12
F 28 1 1 10-50 5-12
F 56 1 1 10-50 5-12
F 37 1 1 10-50 5-12
Sharma et al. 44 USA 2 M 44 refuse surgery 1 3 NA 10 NA 1.72 NA NA NA NA NA NA
F 37 1 3 10 NA
Waung et al. 50 UK 1 F 70 comorbidity 1 3 3 10 NA 1.6 NA 120 NA 2418 NA NA
Lakhtakia et al. 53 India 10 NA NA NA 13 8 p./1
2 p./>1
NA NA NA NA normal NA normal NA normal Abd.pain, acute panc.